Glyscend Therapeutics Announces Preclinical Data at ADA 2021 on the Metabolic Benefits of its Oral Polymer-based Duodenal Exclusion Therapy Kumar Jeetendra | August 10, 2021 Baltimore, MD – Glyscend Inc presented data during the American Diabetes Association 80th Scientific Sessions virtual meeting, June 25-29, 2021, from a study of its proprietary oral polymer duodenal exclusion therapy. The positive data were presented ahead of Glyscend’s phase I clinical trials, which have commenced recruiting healthy subjects in South Australia. Glyscend is developing …
Tips on choosing the right weighing balance for Complete Traceability for MCA 21 CFR Part 11 Compliance Kumar Jeetendra | August 11, 2021 When it comes to regulatory compliance, some may find the prospect of understanding and validating for MCA 21 CFR Part 11 daunting. It’s necessary to prove to regulators that your process and solutions are robust enough to meet their standards, and this will be less of a challenge if you find the right partners to …
DCGI supports mixing trial of Covishield and Covaxin doses: Report Kumar Jeetendra | August 11, 2021 According to reports, the Drugs Controller General of India has approved a trial of mixing two COVID-19 vaccines — Covishield & Covaxin. The mix-and-match study will be conducted by Christian Medical College, Vellore, India Today reported. The nod is granted approximately 11 days after the Subject Expert Committee of the CDSCO (Central Drugs Standard Control …
New Stem cell conveying hydrogel could assist the heart with recuperating myocardial ischemia Kumar Jeetendra | August 11, 2021 When blood vessels that feed the heart become blocked, damage to the heart muscle can occur and this can affect cardiac function. By stimulating the formation of new blood vessels, a new stem-cell-carrying gel helps mice overcome this condition called myocardial Infarction. The stem cell delivery system was developed by scientists from Kansai University, Japan. …
Apollo Proton Cancer Centre sets up India’s first & only Site-specific robotic oncology centre with specialised Surgeons Kumar Jeetendra | August 12, 2021 India, 12th August, 2021: Apollo Proton Cancer Centre, the first Proton Therapy Centre in South Asia & the Middle East gets a state of the art dedicated Robot-Assisted Cancer Surgery Unit. The Robot-Assisted Cancer Surgery Unit will offer patients with comprehensive cancer care under one roof. The unit is equipped with the advanced fourth-generation ‘Da …
Cipla receives final approval for generic version of Durezol® Kumar Jeetendra | August 12, 2021 Mumbai, India; August 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated …
Biotium Launches Optimized Solution for Exosome Detection by Flow Cytometry Kumar Jeetendra | August 12, 2021 Fremont, CA, August 12 2021: — Biotium, a leading supplier and inventor of fluorescent cellular probes for life science research, announces the release of new ExoBrite™ EV Membrane Staining Kits. These kits are designed for fluorescent staining of exosomes or extracellular vesicles (EVs) with little to no background. ExoBrite™ EV Membrane Stains are validated for …
Wockhardt inks agreement to deliver, supply Sputnik vaccine to Dubai-based firm Kumar Jeetendra | August 13, 2021 Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of COVID-19 vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF …
Delta variant of COVID-19 spreading quick in Sri Lanka Kumar Jeetendra | August 13, 2021 The highly transmissible Delta variant of the coronavirus is spreading rapidly across Sri Lanka and comprise around 75 per cent of the new cases reported in the Western province, experts said, warning that the island nation was facing its most decisive fortnight in its fight against the pandemic. There has been a rise in the …
Bharat Biotech’s COVID nasal vaccine gets regulators gesture for holding stage 2, 3 clinical trial Kumar Jeetendra | August 13, 2021 The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator’s nod for conducting phase 2 and 3 clinical trials, the Department of Biotechnology said on Friday. Phase 1 clinical trial has been completed in age groups ranging from 18 to 60 years, it said. “Bharat Biotech’s intranasal vaccine is the first nasal …
Researchers develop AI-based model to analyze cardiovascular illnesses and diabetes Kumar Jeetendra | August 14, 2021 Scientists from South Ural State University (SUSU), along with colleagues from France, Spain, and Egypt, have created a model that can be used to diagnose cardiovascular diseases and diabetes more effectively using artificial intelligence and Internet of Things technology. The Russian Ministry of Science and Higher Education supported this work. In an article published in …
New system joins PC programming and cryo-EM to decide 3D constructions of RNA-only molecules Kumar Jeetendra | August 16, 2021 The single-stranded gene material RNA, also known as RNA, is most well-known for its ability to guide the assembly of proteins and carry the genetic code for viruses such as HIV and SARS-CoV-2. Scientists discovered a hidden talent 40 years ago: It can catalyze chemical reaction in cells, including joining and snipping RNA strands. This …
